34.82BUSD
Type
Common Stock
Exchange
OTCGREY
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0010832176
CUSIP
04016X101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
33.43
PEG Ratio
-
Book Value
90.49
Dividend Share
-
Dividend Yield
-
Earnings Share
16.37
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
2,643,062,016
Gross Profit TTM
1,310,621,952
EBITDA
190,977,504
Profit Margin
40.26%
Return On Assets TTM
-0.21%
Return On Equity TTM
17.36%
Revenue Per Share TTM
43.851
Qtly Revenue Growth YOY
95.70%
Diluted Eps TTM
16.37
Qtly Earnings Growth YOY
0.00%
Trailing PE
33.43
Forward PE
55
Price Sales TTM
13.184
Price Book MRQ
6.0952
Enterprise Value Revenue
12
Enterprise Value EBITDA
85
158.80
4.35%252.26
0.80%472.35
0.79%570.78
0.52%315.81
0.27%561.34
0.16%15.95
0.00%203.85
0.00%79.11
-2.01%100.26
-0.67%